Enzo Biochem (ENZ) Reports In-Line Q1 Loss
Tweet
Share
E-mailGet Alerts ENZ Hot Sheet
Price: $0.31 --0%
Financial Fact:
Benefit (provision) for income taxes: -20K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Benefit (provision) for income taxes: -20K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Enzo Biochem (NYSE: ENZ) reported Q1 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $25.2 million versus the consensus estimate of $25 million.
For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- Mission Produce (AVO) Misses Q3 EPS by 2c; offers outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
